A carregar...
The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder
Introduction: Major depressive disorder (MDD) is the leading cause of disability worldwide, and according to the STAR*D trial, only 33% of patients with MDD responded to initial drug therapy. Augmentation of the leading class of antidepressant treatment, selective serotonin reuptake inhibitors (SSRI...
Na minha lista:
| Publicado no: | Expert Opin Drug Discov |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4841022/ https://ncbi.nlm.nih.gov/pubmed/26971593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/17460441.2016.1160051 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|